相关实验视频

Updated: Jul 25, 2025

CRISPR-Cas9-based Genome Engineering to Generate Jurkat Reporter Models for HIV-1 Infection with Selected Proviral Integration Sites

CRISPR-Cas9-based Genome Engineering to Generate Jurkat Reporter Models for HIV-1 Infection with Selected Proviral Integration Sites

Published on: November 14, 2018

克里斯普尔-Cas12b能够高效地攻击T细胞培养中的HIV前病毒DNA

Minghui Fan¹, Yuanling Bao¹, Ben Berkhout¹

¹Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

|June 28, 2023

概括

Cas12b基因编辑系统有效地使细胞培养中的人类免疫缺陷病毒 (HIV) 失活,为艾滋病毒治愈研究提供了一个有前途的新策略.

科学领域:

分子生物学分子生物学
基因编辑技术的技术
病毒学病毒学

背景情况:

Cas12b是一种用于基因组编辑的新型内核酶.
Cas12b提供了小尺寸和高特异性等优势.
之前的研究表明spCas9和Cas12a抑制了HIV.

研究的目的:

测试Cas12b在细胞培养中抑制艾滋病毒感染传播的有效性.
评估Cas12b在感染的T细胞中实现治愈的潜力.
为了比较Cas12b与Cas9和Cas12a的HIV无活化.

主要方法:

使用Cas12b内核酶与抗HIV导向RNA (gRNA) 进行.
在细胞培养中进行了长期HIV复制研究.
分析了病毒逃逸和治愈的潜力.

主要成果:

Cas12b通过单个gRNA实现了完整的HIV无活化,而Cas9需要两个gRNA.
使用两种gRNA与Cas12b增强了抗HIV功效,并产生了高突变的前病毒.
在Cas9,Cas12a和Cas12b之间观察到突变特征的显著差异,影响了不活化水平.

结论:

由于其效率,Cas12b是HIV无活化的首选系统.
在实验室中证明了CRISPR-Cas12b介导的HIV-1无活化概念的证明.

关键词:

这是一种抗病毒药物.这就是CRISPR-Cas12b.艾滋病毒治愈治愈艾滋病毒隐形病毒向量 (LV) 是一种向量.

更多相关视频

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

Published on: February 28, 2025

相关概念视频

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...